Marker Therapeutics Inc (MRKR) ニュース

Hey Vera, SELL THIS COMPANY!

LC2020. Over 16000 post in over 12 years!! Think DISCOVERY!!!

He is a successful business person, woke up (pun intended) and said, do I really want to be ignored. He walked away and will come back to buy us for ten cents on the dollar. The good news, there's none for us.

https://scitechdaily.com/scientists-unlock-the-secret-to-supercharged-cancer-fighting-t-cells/

I was told it was DEI's fault. Do I win? Thank you.

Any guesses out there, on why he resigned and what’s going to happen next? The correct guess wins a prize.lol

It’s important to keep this guy’s name at the top just for accountability’s sake. Don’t let the link just disappear.

Dr. Huseynov:

https://www.moomoo.com/news/post/44817152/ladenburg-thalmann-maintains-marker-therapeutics-mrkrus-with-buy-rating-raises?level=2&data_ticket=1737645360288002

https://stockanalysis.com/analysts/aydin-huseynov/

https://www.benchmarkcompany.com/the-benchmark-company-expands-its-biotechnology-focus-with-the-addition-of-dr-aydin-huseynov-and-dr-okechukwu-linton/

Thank you 👍

Hopefully they sell the tech long before that because management were a total failure for shareholders, and now it feels like their remnants turned into a One man show.

That would have been in reference to the PII AML trial which was a "potentially pivotal" trial. Pivotal means that if the trial concludes with data above a certain threshold then a PIII is not required. That AML trial has been terminated as they pivot to focussing on their OTS therapy in AML. If that trial, or the PII in lymphoma if they can ever get the damn PI completed, are designated as pivotal then they may be able to avoid a PIII trial but until we have more data and information on the next steps it's not worth thinking about, IMO.

Good for governance. 👏🏼👏🏼 That’s one less conflict to worry about.

>>On January 24, 2025, Mr. John Wilson resigned from the Board of Directors of Marker Therapeutics, Inc. (the “Company”).

Thanks

Good move from Wolfie.
Marker's shareholders built the facility and he got a good deal. No more utility from this sinking abomination, so, bye bye

It’s in an 8-K filing that was alerted by the icon next to the symbol for this board’s header…

MRKR Marker Therapeutics Inc

How did you receive notice? wouldn’t that have to be disclosed to the public? Also wouldn’t that be a bad sign?

I received notice that Wilson from the board of directors resigned. He is the one that bought the manufacturing rights. Will he buy the rest of the company? Time to get the conspiracy theories going. 😁

Phantom Lord, I went back on stock twits and started reading your old posts on there. I read in your older post. There was a possibility of them having the ability to skip a phase 3 trial. Is that possibility no longer available in your opinion? I apologize if this has been answered and I’m not trying to rehash old posts, I am just trying to. look for a silver lining. A light at the end of the tunnel. Lol thank you

I warn people about stock-driven suicides or even stock-driven murders which occur occasionally. Usually contain the same elements: 1) lack of intelligent diversification; 2) repeated averaging down and 3) often, borrowing to "play stocks."

"You’re just asking for more of the same." Actually it can get MUCH worse.
See: https://en.wikipedia.org/wiki/1999_Atlanta_day_trading_firm_shootings

Good thing is they aren't hard to see coming a long way off.

You’re just asking for more of the same. The company appears dead in the water. AlloVir didn’t even want them. How long do you think it’ll remain on the Nasdaq operating like this? The company needs a business oriented CEO who can get deals done pronto, or just fold the thing up and put shareholders out of their misery.

PS- “Precious discussions”…Seriously?

Thank you for the comprehensive reply.

Thanks

Thank you

The company used to, under prior management, trickle data out a few patients at a time. It was poor practice and never really worked out for them. In my precious discussions with Vera he seemed intent on not doing that anymore and holding back data so the release would be more meaningful. Now this past release was pretty uninspiring but I would hope they don't go back to their old ways of releasing small amounts of data at a time. At this point they just need to fully enroll the trial and release data when it's done. I'll accept a follow up on the patients they already released on but trickling the rest of the data out would be a mistake, IMO.

As for partnerships, I have had some indications in prior correspondence that they would be explored. That being said, with where they are right now I would not expect a very prestigious partner if one does materialize. They just don't have enough data to warrant a major partner.

Thank You for the honest opinions. Kind of right with you on it. If this hits $10, I'll bail right with you on half of whatever shares I have then and hold the other half for the future ... and also ... just because I've been playing this TPIV/MRKR game for more than 1/3 of my life, just to keep having fun playing the "Marker Guessing Game".

I honestly don't know what to think about their situation. They hit all of us who reached out to them with their BS that they are on track to reach internal milestones yet they only have 10 patients to present data on after two years. Something isn't adding up and I don't care about their internal milestones. If you don't tell your damn shareholders what you are up to I have to believe you are just doing damage control. They have to know their current progress is completely unacceptable. My stance on the company remains the same. I believe the therapy is promising and will show good enough results to keep it moving forward. This is provided they can get the damn trial fully enrolled.

Where my stance is changing is that as more time goes on with the new management team the more I believe they are completely incompetent. They started off ok with a string of good news and the offloading of the manufacturing facilities to extend their cash runway but the handling of this last data release and financing really opened my eyes to how stupid they really are and that they clearly don't care about their shareholders. They care about appeasing NEA. Hopefully NEA isn't blindly throwing their money away.

As for the price action, I couldn't care less. This has always been retail driven. SP has always been subject to wild swings on minimal volume. I think it just shows how poorly they handled this last release. Clearly no excitement from retail which sends the SP lower and lower. I can't imagine we see much news in the near future that can bring the SP back in the near term but who really knows. At this point we probably have news regarding the initiation of the AML OTS and pancreatic trials before we see any more lymphoma data and they have proven incompetent in running one trial I fail to see how they will be able to manage three at the same time.

I am still holding but my expectations are extremely low at this point. If this sniffs $10 ever again I might bail just be done with the constant price swings and this never able to hold onto gains.

I also have a question for the group, I do believe September 10 was the cut off for the data on the patients to be released. Could it be possible anytime soon that they have more data on more patients that were in the trial, possibly to be released soon? Holding back data so they can give a sweetheart deal to the board members. Is there any possibility that they could be in discussions with a partnership or is that too soon to ask for? Thank you. I also wish for people who are negative and not adding any information, if they could just please leave the group. once again, thank you.

Dear Phantom Lord what is your read on the current situation and price action?
The delay feels a little too long... for them to just include a few patients who went on to live very long.
TIA

I'm buying more at 90 cents though I'm too stupid to sell now and rebuy there given my belief.

I may buy more at $1.11. That's what I paid on March 23, 2023, almost 2 years ago.
This is just so much fun, I can hardly bare it.
Let the games begin.

are we having fun yet?

Read a good book? Actually I recommend several classic investing books in my IHUB bio:

Read most investment classics including:
-Extraordinary Popular Delusions and the Madness of Crowds (1841)
-The intelligent Investor (Ben Graham)
-A Random Walk Down Wall Street (Burton Malkiel)
-Financial Shenanigans (Schilit

That this company still hasn’t been scooped up even with this embarrassing market cap, tells me the trial data isn’t all it’s cracked up to be. Vera needs to go.

I haven't done any research into that ticker or any other stem cell companies so I don't have an opinion.

I'm a retired lawyer. I collect atrocious stocks.

Why are you here? Kick a stock when it is down. Are you with the Kennedie group as well? I would suggest you read a book, you will have a more productive time.

Correction: "I don't own an itty bitty biomeds. Most are rubbish."

s/b I don't own ANY itty bitty biomeds. Most are rubbish.

I don't own an itty bitty biomeds. Most are rubbish.

Maybe you should sell and move on?

What a piece of junk this stock is!

Thank you 👍 I apologize if this is not appropriate, I was just wondering what your opinion was on stem cell companies. I have a boatload of shares of the company LCTX. I was just wondering what your opinion is about that research. Thank you either way if you respond or don’t.

Never trust analyst price targets on these small biotech companies. There are always ulterior motives.

Hey Mod, this idiot exist to stalk me and contributes nothing to either board. Please have him removed. Thanks.

ALL LC2020 Posts are totally IRRELEVANT!!!

It’s important to keep this guy’s name at the top just for accountability’s sake. Don’t let the link just disappear.

Dr. Huseynov:

https://www.moomoo.com/news/post/44817152/ladenburg-thalmann-maintains-marker-therapeutics-mrkrus-with-buy-rating-raises?level=2&data_ticket=1737645360288002

https://stockanalysis.com/analysts/aydin-huseynov/

https://www.benchmarkcompany.com/the-benchmark-company-expands-its-biotechnology-focus-with-the-addition-of-dr-aydin-huseynov-and-dr-okechukwu-linton/

Yep.  Professor Vera and that Director guy who now owns Marker's manufacturing wing, are not giving shareholders anything to smile about.  

Most likely answer is he was used to suck in retail then trap them.  

Of course, you'll be tempted to average down... and down and down. Most of us know the drill. Seen it many times, including the BKs and suicides


BTW, I had another good day with my blue chips.

Oh My, well it's just set it and forget it for the next 12 months. There will be no reason for a large price upswing without good new data news, and THAT is a Long Way Off.
If it gets below $1.50, I might be tempted to buy more, but not now.

Small biomeds are jokes and so are the "analysts." Please people, smarten up. Some here, lose over and over.

How and why did this analyst give this company a double digit price target after speaking to the company? this is very frustrating.